BioMarin Pharmaceutical Inc. (BIT:1BMRN)

Marinus Pharmaceuticals Statistics

Total Valuation

BIT:1BMRN has a market cap or net worth of EUR 9.44 billion. The enterprise value is 8.73 billion.

Market Cap	9.44B
Enterprise Value	8.73B

Important Dates

The last earnings date was Friday, August 1, 2025.

Earnings Date	Aug 1, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	192.01M
Shares Outstanding	n/a
Shares Change (YoY)	+0.35%
Shares Change (QoQ)	+0.31%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	179.60M

Valuation Ratios

The trailing PE ratio is 16.86 and the forward PE ratio is 12.75.

PE Ratio	16.86
Forward PE	12.75
PS Ratio	3.62
PB Ratio	1.84
P/TBV Ratio	1.98
P/FCF Ratio	15.95
P/OCF Ratio	14.45
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 10.50, with an EV/FCF ratio of 14.75.

EV / Earnings	15.59
EV / Sales	3.32
EV / EBITDA	10.50
EV / EBIT	11.68
EV / FCF	14.75

Financial Position

The company has a current ratio of 5.56, with a Debt / Equity ratio of 0.10.

Current Ratio	5.56
Quick Ratio	3.34
Debt / Equity	0.10
Debt / EBITDA	0.62
Debt / FCF	0.87
Interest Coverage	78.64

Financial Efficiency

Return on equity (ROE) is 11.62% and return on invested capital (ROIC) is 8.37%.

Return on Equity (ROE)	11.62%
Return on Assets (ROA)	7.50%
Return on Invested Capital (ROIC)	8.37%
Return on Capital Employed (ROCE)	12.88%
Revenue Per Employee	858,113
Profits Per Employee	184,092
Employee Count	3,040
Asset Turnover	0.42
Inventory Turnover	0.44

Taxes

In the past 12 months, BIT:1BMRN has paid 155.65 million in taxes.

Income Tax	155.65M
Effective Tax Rate	21.76%

Stock Price Statistics

The stock price has decreased by -35.07% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-35.07%
50-Day Moving Average	49.14
200-Day Moving Average	58.11
Relative Strength Index (RSI)	49.42
Average Volume (20 Days)	20

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.64

Income Statement

In the last 12 months, BIT:1BMRN had revenue of EUR 2.61 billion and earned 559.64 million in profits. Earnings per share was 2.89.

Revenue	2.61B
Gross Profit	2.13B
Operating Income	742.43M
Pretax Income	715.29M
Net Income	559.64M
EBITDA	813.31M
EBIT	742.43M
Earnings Per Share (EPS)	2.89

Balance Sheet

The company has 1.22 billion in cash and 514.19 million in debt, giving a net cash position of 705.26 million.

Cash & Cash Equivalents	1.22B
Total Debt	514.19M
Net Cash	705.26M
Net Cash Per Share	n/a
Equity (Book Value)	5.13B
Book Value Per Share	26.73
Working Capital	2.66B

Cash Flow

In the last 12 months, operating cash flow was 652.91 million and capital expenditures -61.19 million, giving a free cash flow of 591.72 million.

Operating Cash Flow	652.91M
Capital Expenditures	-61.19M
Free Cash Flow	591.72M
FCF Per Share	n/a

Margins

Gross margin is 81.80%, with operating and profit margins of 28.46% and 21.45%.

Gross Margin	81.80%
Operating Margin	28.46%
Pretax Margin	27.42%
Profit Margin	21.45%
EBITDA Margin	31.18%
EBIT Margin	28.46%
FCF Margin	22.68%

Dividends & Yields

BIT:1BMRN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.35%
Shareholder Yield	n/a
Earnings Yield	5.93%
FCF Yield	6.27%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BIT:1BMRN has an Altman Z-Score of 6.89 and a Piotroski F-Score of 7.

Altman Z-Score	6.89
Piotroski F-Score	7